Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

ENhancing Recovery in CHildren Undergoing Surgery (ENRICH-US)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04060303
Recruitment Status : Recruiting
First Posted : August 19, 2019
Last Update Posted : July 10, 2020
Sponsor:
Information provided by (Responsible Party):
Mehul Raval, Northwestern University

Brief Summary:
Initiated in the 1990s, perioperative Enhanced Recovery Protocols (ERPs) have progressively gained traction in a wide range of adult surgical disciplines and have decreased hospital length of stay (LOS), in-hospital costs, complications, and result in a markedly improved patient care experience that mitigates the physiologic stress of surgery and hastens recovery. Implementation of ERPs in pediatric surgery is lagging and concerted efforts to demonstrate both clinical effectiveness and to examine obstacles to implementation are needed. Specifically, pediatric patients with inflammatory bowel disease (IBD) undergoing elective abdominal surgery represent an ideal population in which to study the implementation of ERPs. Almost one third of patients with Crohn's disease (CD) and a quarter of patients with Ulcerative Colitis (UC) present before age 20. Up to three-quarters of CD patients require GI surgery for medically refractory disease and all patients with UC require colectomy to either manage severe disease or to mitigate cancer risks. Over the past four years, investigators modified existing adult ERPs to meet the needs of pediatric patients undergoing elective GI surgery. Based on the positive results of a pilot study, the investigators propose to conduct a multicenter, prospective, pragmatic, study using a stepped-wedge, cluster, randomized controlled trial design to evaluate the effectiveness of ERPs while assessing implementation fidelity, sustainability, and site-specific adaptations. The cluster randomized trial design is ideally suited for this type of pragmatic intervention implementation. The National Implementation Research Network's five Active Implementation Frameworks (AIFs), which identifies competency, organization, and leadership as drivers of implementation, empowers team collaboration, and facilitates rapid-cycle evaluation, will be used to optimize implementation. The investigators propose to conduct the ENhancing Recovery In CHildren Undergoing Surgery (ENRICH-US) Study in 18 US hospitals participating in the Pediatric Surgical Research Collaborative (PedSRC) by implementing and evaluating the effectiveness of the Pediatric ERP in GI Surgery on clinical outcomes for pediatric IBD patients and by measuring by fidelity and sustainability of the intervention while identifying organizational, leadership, and competency-based drivers of improved ERP implementation and sustainability.

Condition or disease Intervention/treatment Phase
Inflammatory Bowel Disease Crohn's Disease Ulcerative Colitis Procedure: Perioperative surgical care Not Applicable

Detailed Description:

This application proposes to implement an ERP for pediatric patients with inflammatory bowel disease (IBD), encompassing Crohn's Disease (CD) and Ulcerative Colitis (UC), and undergoing elective abdominal surgery. They represent an ideal population in which to study the implementation of ERPs because almost one third of patients with CD present before age 20 and up to three-quarters of CD patients require gastrointestinal (GI) surgery for medically refractory disease. A quarter of UC patients present before age 20 and all patients with UC require colectomy to either manage severe disease or mitigate cancer risks. The GI surgical procedures performed in children with IBD are similar to the adult procedures for which ERPs have been well tested and validated.

The study team has previously modified existing adult ERPs to meet the needs of pediatric patients undergoing elective GI surgery, primarily for IBD, by conducting (a) a systematic literature review, (b) a national survey to assess readiness for implementation, and (c) an expert panel adjudication of ERP elements. The investigators also conducted a pilot study to assess the feasibility, safety, and preliminary effectiveness of the pediatric ERP in 79 pediatric patients who underwent elective GI surgery. Patient and provider education materials were created, a learning collaborative explored drivers and obstacles to implementation, patient advocates were engaged to enhance the quality improvement process, and data were routinely fed back to the implementation team members. The pilot study demonstrated a 50% decrease in LOS, from 5 to 3 days, near elimination of intraoperative and post-operative opioid use, and a 30% decrease in perioperative fluid administration, without any increase in post-surgical complications or re-hospitalization.

Based on these promising results, the investigators propose the ENhancing Recovery In CHildren Undergoing Surgery (ENRICH-US) Study in 18 US hospitals that participate in the Pediatric Surgical Research Collaborative (PedSRC). This multicenter study will use a stepped-wedge, cluster-randomized, pragmatic clinical trial design to evaluate the effectiveness of ENRICH-US while also assessing implementation fidelity, sustainability, and site-specific adaptations. The investigators will optimize implementation using the National Implementation Research Network's five Active Implementation Frameworks (AIFs), which identify competency, organization, and leadership as drivers of implementation and empower team collaboration and facilitate rapid-cycle evaluation.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 1260 participants
Allocation: Randomized
Intervention Model: Sequential Assignment
Intervention Model Description: A stepped-wedge, cluster-randomized study design will be used in which the participating sites will be randomly assigned to one of three clusters with each cluster, in turn, being randomly assigned to an intervention start period.
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Assessing Effectiveness and Implementation of a Perioperative Enhanced Recovery Protocol for Children With Inflammatory Bowel Disease
Actual Study Start Date : September 1, 2019
Estimated Primary Completion Date : December 1, 2023
Estimated Study Completion Date : May 1, 2024

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: ENRICH-US Implementation- early

Baseline, pre-intervention data will be collected. This phase consists primarily of individual-level patient (ages 10-18 years undergoing elective GI surgery for IBD) data collection. This phase involves abstraction of existing electronic health records data by the Site Coordinator about current, standard perioperative care received by patients. Patients and parents will complete web-based HRQoL assessments preoperatively, and 5 days and 4-6 weeks post-operatively. Site-specific barriers and facilitators to implementation will be assessed by semi-structured, telephone interviews, conducted by each Site's PI and Coordinator.

Intervention phase will span 12 months with an implementation curriculum. Sites will be randomized to this implementation phase based on stepped-wedge cluster assignment. A sustainability phase will collect post intervention data.

Procedure: Perioperative surgical care
The ENRICH-US Protocol includes perioperative counseling and education, maintaining euvolumia through limited perioperative fasting and limited intraoperative fluid resuscitation, early enteral intake and mobilization, limited use of opioids, and non-routine use of surgical drains and tubes. Elements span the pre-, intra-, and post-operative experience for patients and involve care coordination among surgery, anesthesia, and nursing providers. Though individually simple, the concomitant implementation of the combined elements results in a markedly improved patient care experience that mitigates the physiologic stress of surgery and hastens recovery.

Active Comparator: ENRICH-US Implementation- mid

Baseline, pre-intervention data will be collected. This phase consists primarily of individual-level patient (ages 10-18 years undergoing elective GI surgery for IBD) data collection. This phase involves abstraction of existing electronic health records data by the Site Coordinator about current, standard perioperative care received by patients. Patients and parents will complete web-based HRQoL assessments preoperatively, and 5 days and 4-6 weeks post-operatively. Site-specific barriers and facilitators to implementation will be assessed by semi-structured, telephone interviews, conducted by each Site's PI and Coordinator.

Intervention phase will span 12 months with an implementation curriculum. Sites will be randomized to this implementation phase based on stepped-wedge cluster assignment. A sustainability phase will collect post intervention data.

Procedure: Perioperative surgical care
The ENRICH-US Protocol includes perioperative counseling and education, maintaining euvolumia through limited perioperative fasting and limited intraoperative fluid resuscitation, early enteral intake and mobilization, limited use of opioids, and non-routine use of surgical drains and tubes. Elements span the pre-, intra-, and post-operative experience for patients and involve care coordination among surgery, anesthesia, and nursing providers. Though individually simple, the concomitant implementation of the combined elements results in a markedly improved patient care experience that mitigates the physiologic stress of surgery and hastens recovery.

Active Comparator: ENRICH-US Implementation- late

Baseline, pre-intervention data will be collected. This phase consists primarily of individual-level patient (ages 10-18 years undergoing elective GI surgery for IBD) data collection. This phase involves abstraction of existing electronic health records data by the Site Coordinator about current, standard perioperative care received by patients. Patients and parents will complete web-based HRQoL assessments preoperatively, and 5 days and 4-6 weeks post-operatively. Site-specific barriers and facilitators to implementation will be assessed by semi-structured, telephone interviews, conducted by each Site's PI and Coordinator.

Intervention phase will span 12 months with an implementation curriculum. Sites will be randomized to this implementation phase based on stepped-wedge cluster assignment. A sustainability phase will collect post intervention data.

Procedure: Perioperative surgical care
The ENRICH-US Protocol includes perioperative counseling and education, maintaining euvolumia through limited perioperative fasting and limited intraoperative fluid resuscitation, early enteral intake and mobilization, limited use of opioids, and non-routine use of surgical drains and tubes. Elements span the pre-, intra-, and post-operative experience for patients and involve care coordination among surgery, anesthesia, and nursing providers. Though individually simple, the concomitant implementation of the combined elements results in a markedly improved patient care experience that mitigates the physiologic stress of surgery and hastens recovery.




Primary Outcome Measures :
  1. Length of stay (LOS) [ Time Frame: Up to 30 days after surgery ]
    Measured in days from surgery to discharge.


Secondary Outcome Measures :
  1. Intraoperative fluid use [ Time Frame: Intraoperative ]
    intravenous fluids given during surgery (measured in mL/kg)

  2. Surgical Complications [ Time Frame: Up to 30 days after surgery ]
    wound infections, pneumonia, urinary tract infections within 30 days of surgery

  3. Hospital readmission [ Time Frame: Up to 30 days after surgery ]
    Post discharge hospital readmission within 30 days of surgery.

  4. Intraoperative opioid use [ Time Frame: Intraoperative ]
    opioids used during surgery measured in morphine equivalents mg/kg

  5. Postoperative opioid use [ Time Frame: Up to 30 days after surgery ]
    opioids from surgery until discharge measured in morphine equivalents mg/kg

  6. Post-discharge opioid prescribed [ Time Frame: Up to 30 days after surgery ]
    Opioids prescribed at discharge measured in morphine equivalents mg/kg

  7. Time to regular diet [ Time Frame: Up to 30 days after surgery ]
    Time from intestinal surgery to resumption of regular diet (measured in days)

  8. Preoperative Quality of Life assessment [ Time Frame: Baseline (prior to surgery) ]
    Health Related Quality of Life assessment using Pediatric Quality of Life (PedsQL) inventory. Total scores spanning all domains (Physical Functioning, Emotional Functioning, Social Functioning, and School Functioning). Scores total to 100. Scores >90 considered normal. This measurement will be collected prior to surgery.

  9. Immediate post-operative Quality of Life assessment [ Time Frame: 48 hours after surgery ]
    Health Related Quality of Life assessments: Pediatric Quality of Life (PedsQL) inventory. Total scores spanning all domains (Physical Functioning, Emotional Functioning, Social Functioning, and School Functioning). Scores total to 100. Scores >90 considered normal. This measurement will be collected within 48 hours after surgery

  10. Long-term post-operative Quality of Life assessment [ Time Frame: 2 weeks after surgery ]
    Health Related Quality of Life assessments: Pediatric Quality of Life (PedsQL) inventory. Total scores spanning all domains (Physical Functioning, Emotional Functioning, Social Functioning, and School Functioning). Scores total to 100. Scores >90 considered normal. This measurement will be collected 2 weeks after surgery.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   10 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Pediatric patients ages 10-18
  • Clinical diagnosis of Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis)
  • Undergoing elective gastrointestinal/colorectal surgical procedures

Exclusion Criteria:

  • Children undergoing emergent/urgent gastrointestinal/colorectal surgical procedures
  • Patients/families who cannot read and write English or Spanish

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04060303


Contacts
Layout table for location contacts
Contact: Mehul Raval, MD, MS 3122274210 mraval@luriechildrens.org

Locations
Layout table for location information
United States, Illinois
Northwestern University Recruiting
Chicago, Illinois, United States, 60611
Contact: Mehul Raval, MD, MS         
Sponsors and Collaborators
Northwestern University
Layout table for additonal information
Responsible Party: Mehul Raval, Associate Professor of Surgery and Pediatrics, Northwestern University
ClinicalTrials.gov Identifier: NCT04060303    
Other Study ID Numbers: ENRICH-US 2019
First Posted: August 19, 2019    Key Record Dates
Last Update Posted: July 10, 2020
Last Verified: July 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: All data collected during the study will be made available such that further advancement of ERP principles will be made possible by building upon these data. In addition to the peer-reviewed publication of study results and the dissemination of findings through publicly available websites, blogs, and newsletters, the PI and Biostatistics Director will create a patient-deidentified data set that will be made publicly available to researchers. We have included a request for funds to curate this dataset for public use. It will include clinical data and outcomes collected through REDCap for the complete ENRICH-US study, as well as, raw data for the PedsQL health-related quality of life surveys. All data will be fully de-identified. A copy of the study protocol, data definition dictionary, and public use file with instructions will also be generated for ease of use. Data will be made available in a format that will easily be used in mainstream software analysis packages (e.g., ASCII, SAS).

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Mehul Raval, Northwestern University:
Pediatric Surgery
Implementation
Quality Improvement
Enhanced Recovery Protocols
Additional relevant MeSH terms:
Layout table for MeSH terms
Crohn Disease
Colitis, Ulcerative
Intestinal Diseases
Inflammatory Bowel Diseases
Gastroenteritis
Gastrointestinal Diseases
Digestive System Diseases
Colitis
Colonic Diseases